Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
170.95
4.25 (2.55%)
BSENSE

Dec 05

BSE+NSE Vol: 65.63 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
10.54
10.47
10.42
10.37
10.31
10.31
Share Warrants & Outstandings
Total Reserve
1,033.54
949.00
864.59
798.40
788.10
725.30
Shareholder's Funds
1,050.38
967.19
883.90
818.70
808.25
735.61
Minority Interest
41.47
35.79
33.53
27.76
19.66
14.76
Long-Term Borrowings
19.85
35.59
40.69
23.22
32.60
37.24
Secured Loans
19.85
35.59
40.69
23.22
32.60
37.24
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.30
3.59
-3.33
1.32
8.21
3.55
Other Long Term Liabilities
12.77
9.34
2.79
3.58
1.93
3.09
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
4.36
2.67
2.69
1.07
2.50
2.44
Total Non-Current Liabilities
37.28
51.20
42.84
29.20
45.24
46.32
Current Liabilities
Trade Payables
71.42
60.97
86.39
92.61
74.22
89.92
Other Current Liabilities
48.53
44.23
49.49
53.47
34.60
60.80
Short Term Borrowings
51.13
52.21
57.38
81.73
86.15
66.39
Short Term Provisions
0.64
0.00
0.00
5.28
8.66
13.43
Total Current Liabilities
171.72
157.41
193.26
233.09
203.64
230.53
Total Liabilities
1,300.84
1,211.59
1,153.52
1,108.75
1,076.79
1,027.22
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
531.06
467.78
458.74
343.41
285.10
0.00
Less: Accumulated Depreciation
126.11
98.41
80.69
62.65
51.38
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
404.95
369.37
378.05
280.76
233.72
240.97
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
20.71
7.83
2.80
22.15
2.39
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
5.07
4.30
3.53
3.08
0.70
0.72
Long Term Loans & Advances
16.65
14.72
17.62
24.42
12.62
14.56
Other Non Current Assets
26.96
4.50
54.16
1.47
62.15
1.24
Total Non-Current Assets
474.33
400.72
456.15
331.89
311.59
257.48
Current Assets Loans & Advances
Current Investments
0.00
0.56
4.96
0.00
0.00
0.00
Inventories
125.73
118.45
103.06
123.94
98.93
74.14
Sundry Debtors
438.36
404.35
385.17
392.75
463.82
547.91
Cash and Bank
213.31
215.62
102.99
177.53
144.55
103.32
Other Current Assets
21.67
16.63
8.25
15.20
18.98
16.63
Short Term Loans and Advances
27.44
55.28
92.94
67.44
38.92
27.74
Total Current Assets
826.51
810.87
697.37
776.86
765.20
769.74
Net Current Assets (Including Current Investments)
654.79
653.47
504.11
543.77
561.56
539.21
Total Current Assets Excluding Current Investments
826.51
810.32
692.41
776.86
765.20
769.74
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,300.84
1,211.59
1,153.52
1,108.75
1,076.79
1,027.22
Contingent Liabilities
7.09
6.19
2.63
1.53
15.21
13.85
Total Debt
70.97
87.81
98.07
104.96
118.75
103.62
Book Value per share (adjusted)
99.68
92.38
84.87
78.97
78.36
71.32
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -19.18% vs -10.46% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 36.72% vs 234.77% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 12.85% vs -0.96% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 17.91% vs 21.81% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 1.93% vs 16.28% in Mar 2024

Compare Balance Sheet Results of Bliss GVS Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.54
10.48
0.06
0.57%
Share Warrants & Outstandings
Total Reserve
1,033.54
490.04
543.50
110.91%
Shareholder's Funds
1,050.38
505.77
544.61
107.68%
Minority Interest
41.47
0.00
41.47
0.00%
Long-Term Borrowings
19.85
0.00
19.85
0.00%
Secured Loans
19.85
0.00
19.85
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.30
-0.28
0.58
207.14%
Other Long Term Liabilities
12.77
2.35
10.42
443.40%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
4.36
2.88
1.48
51.39%
Total Non-Current Liabilities
37.28
4.95
32.33
653.13%
Current Liabilities
Trade Payables
71.42
167.24
-95.82
-57.29%
Other Current Liabilities
48.53
53.53
-5.00
-9.34%
Short Term Borrowings
51.13
27.12
24.01
88.53%
Short Term Provisions
0.64
1.56
-0.92
-58.97%
Total Current Liabilities
171.72
249.44
-77.72
-31.16%
Total Liabilities
1,300.84
760.17
540.67
71.12%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
531.06
318.52
212.54
66.73%
Less: Accumulated Depreciation
126.11
118.36
7.75
6.55%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
404.95
200.16
204.79
102.31%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
20.71
3.20
17.51
547.19%
Intangible assets under development
0.00
2.12
-2.12
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
5.07
0.00
5.07
0.00%
Long Term Loans & Advances
16.65
5.22
11.43
218.97%
Other Non Current Assets
26.96
1.12
25.84
2,307.14%
Total Non-Current Assets
474.33
235.04
239.29
101.81%
Current Assets Loans & Advances
Current Investments
0.00
223.37
-223.37
-100.00%
Inventories
125.73
81.38
44.35
54.50%
Sundry Debtors
438.36
166.86
271.50
162.71%
Cash and Bank
213.31
15.93
197.38
1,239.05%
Other Current Assets
21.67
4.92
16.75
340.45%
Short Term Loans and Advances
27.44
32.67
-5.23
-16.01%
Total Current Assets
826.51
525.13
301.38
57.39%
Net Current Assets (Including Current Investments)
654.79
275.69
379.10
137.51%
Total Current Assets Excluding Current Investments
826.51
301.76
524.75
173.90%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,300.84
760.17
540.67
71.12%
Contingent Liabilities
7.09
0.00
7.09
0.00%
Total Debt
70.97
0.00
70.97
0.00%
Book Value per share (adjusted)
99.68
241.30
-141.62
-58.69%
Annual - Borrowings
Borrowings 70.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -19.18% vs -10.46% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 12.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 36.72% vs 234.77% in Mar 2024

Annual - Fixed Assets
Fixed Assets 425.66 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.85% vs -0.96% in Mar 2024

Annual - Investments
Investments 5.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 17.91% vs 21.81% in Mar 2024

Annual - Current Assets
Current Assets 826.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.93% vs 16.28% in Mar 2024